David Charles Lubner
Director · 3 filings · Latest: Jun 2, 2026
Arcellx, Inc.
CRESCENT BIOPHARMA, INC.
Dyne Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|
DYN | David Charles Lubner | Director | Apr 24, 2026 | Gift | $0.00 | 53,625 | — | 0 | |
ACLX | David Charles Lubner | Director | Apr 28, 2026 | U | — | 21,659 | — | 0 | |